NCT06699719

Brief Summary

The goal of this trial is to examine the feasibility of administering an online writing intervention to patients diagnosed with Major Depressive Disorder, and whether this intervention impacts symptoms of depression. It also examines the impact of the intervention on symptoms of anxiety, personal functioning, and perceived problem complexity, and how participants experience the intervention. The main questions the trial aims to answer are: Will participants randomized to the online writing intervention complete at least three sessions? Is the writing intervention associated with a reduction in symptoms of depression and anxiety, perceived problem complexity, and/or an improvement in personal functioning? What are participants' perceptions of the online writing intervention, including both positive and negative experiences? Participants will: Complete four sessions of an online writing intervention or no writing intervention over the course of one week Complete questionnaires before and after the intervention, and at a one-month follow-up Complete qualitative interviews probing into their experiences with the intervention

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2022

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

November 8, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 21, 2024

Completed
Last Updated

November 21, 2024

Status Verified

October 1, 2024

Enrollment Period

3.2 years

First QC Date

November 8, 2024

Last Update Submit

November 19, 2024

Conditions

Keywords

Expressive writingMajor DepressionOnline interventionDigital mental health

Outcome Measures

Primary Outcomes (2)

  • Feasibility of completing EW

    Feasibility is defined as 70% of EW participants completing at least three 20-minute sessions of EW.

    Feasibility is determined immediately following the completion of the third writing session, which is at minimum after 3 days or one week, on average.

  • Depressive symptoms

    Severity of depressive symptoms, as assessed via the Patient Health Questionnaire (PHQ-9); values range from 0-27 with higher scores indicating greater symptom severity (or worse outcome).

    On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups

Secondary Outcomes (3)

  • Anxiety symptoms

    On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups

  • Impaired functioning

    On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups

  • Problem Complexity

    On the next day after the fourth online writing session for participants assigned to EW or after one week for control participants, and at a one-month follow-up for both groups

Study Arms (2)

Control

NO INTERVENTION

Participants are not asked to complete the online writing intervention

Expressive writing

EXPERIMENTAL

Participants are asked to complete four 20-minute sessions of an online writing task on consecutive days.

Behavioral: Expressive writing

Interventions

Participants are asked to complete four 20-minute sessions of a writing task on consecutive days, which is sent to their email address via an online link. Participants are instructed "for the next 20 minutes to please use the provided box to write their very deepest thoughts and feelings about a negative issue or personal problem that they are currently being affected by. In their writing, they are encouraged to let go and explore their emotions and thoughts regarding this issue or problem, and to not worry about spelling or grammar. They are asked to consider setting a timer or have a clock handy to make sure they write for 20 minutes." Instructions are accompanied by a text box, which allows participants to write freely for the allotted time.

Also known as: EW, online writing intervention
Expressive writing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults aged 18 or older
  • assessed by a psychiatrist and received a diagnosis of MDD with or without another co-morbid condition
  • access to the internet and an email address

You may not qualify if:

  • \- no ability to understand, speak, or write in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Addiction and Mental Health

Toronto, Ontario, M5T1R8, Canada

Location

Related Publications (10)

  • Gratzer D, Goldbloom D. Making Evidence-Based Psychotherapy More Accessible in Canada. Can J Psychiatry. 2016 Oct;61(10):618-23. doi: 10.1177/0706743716642416. Epub 2016 Apr 5. No abstract available.

    PMID: 27310234BACKGROUND
  • Hayes AM, Feldman GC, Beevers CG, Laurenceau JP, Cardaciotto L, Lewis-Smith J. Discontinuities and cognitive changes in an exposure-based cognitive therapy for depression. J Consult Clin Psychol. 2007 Jun;75(3):409-421. doi: 10.1037/0022-006X.75.3.409.

    PMID: 17563158BACKGROUND
  • Sbarra DA, Boals A, Mason AE, Larson GM, Mehl MR. Expressive Writing Can Impede Emotional Recovery Following Marital Separation. Clin Psychol Sci. 2013 Mar 18;1(2):120-134. doi: 10.1177/2167702612469801.

    PMID: 25606351BACKGROUND
  • Kovac SH, Range LM. Does writing about suicidal thoughts and feelings reduce them? Suicide Life Threat Behav. 2002 Winter;32(4):428-40. doi: 10.1521/suli.32.4.428.22335.

    PMID: 12501967BACKGROUND
  • Sloan DM, Marx BP, Epstein EM, Lexington JM. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. Epub 2007 Jan 18.

    PMID: 17499082BACKGROUND
  • Gortner EM, Rude SS, Pennebaker JW. Benefits of expressive writing in lowering rumination and depressive symptoms. Behav Ther. 2006 Sep;37(3):292-303. doi: 10.1016/j.beth.2006.01.004. Epub 2006 May 30.

    PMID: 16942980BACKGROUND
  • Krpan KM, Kross E, Berman MG, Deldin PJ, Askren MK, Jonides J. An everyday activity as a treatment for depression: the benefits of expressive writing for people diagnosed with major depressive disorder. J Affect Disord. 2013 Sep 25;150(3):1148-51. doi: 10.1016/j.jad.2013.05.065. Epub 2013 Jun 18.

    PMID: 23790815BACKGROUND
  • Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006 Nov;132(6):823-65. doi: 10.1037/0033-2909.132.6.823.

    PMID: 17073523BACKGROUND
  • Chiu M, Lebenbaum M, Cheng J, de Oliveira C, Kurdyak P. The direct healthcare costs associated with psychological distress and major depression: A population-based cohort study in Ontario, Canada. PLoS One. 2017 Sep 5;12(9):e0184268. doi: 10.1371/journal.pone.0184268. eCollection 2017.

    PMID: 28873469BACKGROUND
  • Baikie KA, Geerligs L, Wilhelm K. Expressive writing and positive writing for participants with mood disorders: an online randomized controlled trial. J Affect Disord. 2012 Feb;136(3):310-9. doi: 10.1016/j.jad.2011.11.032. Epub 2011 Dec 30.

    PMID: 22209127BACKGROUND

MeSH Terms

Conditions

Depressive Disorder, MajorGeneralized Anxiety Disorder

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersAnxiety Disorders

Study Officials

  • Benoit H Mulsant, MD, MS, FRCPC, DLFAPA

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Only one intervention arm is available to study participants (i.e., an online EW intervention), and participants are randomized to one of two arms: 1) the intervention, which is to complete four sessions of writing online or 2) no intervention (i.e., control).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2024

First Posted

November 21, 2024

Study Start

March 27, 2019

Primary Completion

June 14, 2022

Study Completion

June 14, 2022

Last Updated

November 21, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

IPD for this study cannot be made openly-available, because the investigators do not have ethical approval to share personal identifiable, patient-level data outside of the research study. However, code used to generate results is openly available on the Open Science Framework (OSF).

Locations